← Back to patent-cliff list
XH-S003
Tier C — Watch / tradeXH-S003
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：CFB
Indications (approved)：阵发性血红蛋白尿症, 免疫球蛋白a肾病
Regional status
US
-
EU
-
China
Phase III
2026-07-22
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of XH-S003?
Approved indications include: 阵发性血红蛋白尿症, 免疫球蛋白a肾病.
When does the XH-S003 patent expire?
No public expiry year is available for XH-S003 yet; this page updates once verified.
How do I get a quote for XH-S003 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29